ask="0.3600"
ask_size="40000"
average_daily_volume="1841800"
bid="0.2915"
bid_size="7500"
book_value="0.1680"
change="+0.0016"
change_from_200_day_moving_average="-0.0209"
change_from_50_day_moving_average="0.0189"
change_from_52_week_high="-0.7961"
change_From_52_week_low="0.0419"
change_in_percent="+0.4964%"
close="0.3239"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3280"
high_52_weeks="1.1200"
last_trade_date="2/7/2017"
last_trade_price="0.3239"
last_trade_size="3100"
last_trade_time="3:59pm"
low="0.3200"
low_52_weeks="0.2820"
market_capitalization="83.29M"
moving_average_200_day="0.3448"
moving_average_50_day="0.3050"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3225"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-6.0664%"
percent_change_from_50_day_moving_average="+6.1967%"
percent_change_from_52_week_high="-71.0804%"
percent_change_from_52_week_low="+14.8582%"
previous_close="0.3223"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.9185"
price_per_sales="1.5215"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.3300"
stock_exchange="NCM"
symbol="PPHM"
volume="1578637"
weeks_range_52="0.2820 - 1.1200"
